IBM has been selling hardware units. They sold their point of sale equipment unit. They are moving into software and have bought companies that support their plan for higher profit margins. If you go to slide 14, you will see where the growth is going to come from. You can count on IBM to meet their earnings number.
Buy IBM To Benefit From Rising Software Profitability [View article]
Pisani is wrong. It in't hard to get earnings growth when IBM sells higher margin products like software. He doesn't understand their plan. I do not know why I have CNBC on when it has to be the worst channel for information.
Enterprise IT stocks slump following IBM's (IBM -3.7%) Q3 revenue miss, which had much to do with drops in mainframe, storage, and middleware sales. Earnings call remarks about weak September demand aren't helping either, though some might be encouraged IBM's Chinese sales rose 19% Y/Y at a time when others (I, II) are seeing Chinese demand slump. EMC (EMC -1.5%), VMware (VMW -1.9%), Citrix (CTXS -2.2%), Red Hat (RHT -1.7%), and Tibco (TIBX -3.6%) are among the losers. [View news story]
Buy IBM To Benefit From Rising Software Profitability [View article]
If you buy stocks when they sell off after earnings, you will make more money than if you buy stocks after they have popped. This selloff is overdone. And IBM is probably buying back their own stock now. IBM has a plan for growth to earnings of $15 this year, with a goal of 50% of earnings coming from high margin software in the next few years. They make their earnings number. This is what matters.
IBM (IBM): Q3 EPS of $3.62 in-line. Revenue of $24.75B (-5% Y/Y) misses by $630M. Expects 2012 EPS of at least $15.10 vs. $15.14 consensus. Shares -3.2% AH. (PR) [View news story]
You need to go listen to the conference call as they have a plan for growth. See slide # 14 or just read the article on Bloomberg Businessweek. Right now there is some weakness in N. America and Europe. Growth was good in Russia, China, and India. If you buy stocks when they sell off after earnings, you can make more money than if you buy stocks that have popped. This was in an article by Mark Hulbert on Marketwatch earlier in the year. I am not selling my IBM stock.
Bill Gross: 'The Ring Of Fire' And Your Income Portfolio [View article]
President Obama has a plan to cut $4T in ten years but the Republican teaparty said no as they have signed the Grover Norquist pledge. There are ideas out there but just no agreement between the two political parties. As we reach the end of the Bush tax cuts, the general thought is that the two parties will negotiate a deal. You don't want all of your assets in one or two classes for the long term. Most recommendations I have seen is for no more than 10% of your portfolio in gold.
Earnings Season Launches Under Cloud Of Low Expectations [View article]
According to a study that was on Marketwatch earlier in the year, I believe written by Mark Hulbert, you can make more money buying stocks that drop after earnings than those stocks that have gone up. If a stock has moved up alot, then there may not be much room left to run. Look at Fedex, up 10% in one week after a bad earnings report and lowering next year's forecast. Today QCOR is up over 4%. It sold off because of Aetna's decision. I guess Wall Street analysts think that insurance companies will continue to determine people's healthcare decisions and that Romney will repeal the Healthcare Affordability Act. I disagree and do not think that people will go along with that. Even if Romney is elected, I think people will demand the right to switch insurers if they do not cover their doctor's prescription.
To Fight The Fear, Eventually You Have To Shake Your Shorts [View article]
It takes a while for shorts to realize that they are going to have to pay the dividend. The ex-dividend date for QCOR is 10/29. 44% short. I think QCOR will pop on earnings which is 10/22 after the conference call when the media will surely mention the dividend payment to the shorts.
Heavily-shorted Questcor (QCOR +6.1%) surges after receiving more positive sell-side commentary (previous), this time from Jefferies, which is upgrading shares to Buy. Analyst Biren Amin believes investors are pricing Questcor as if almost no insurers will provide coverage for its Acthar gel for treating nephrotic syndrome or MS, something he considers unrealistic. [View news story]
5 Biotech Companies With Major Market-Moving Announcements To Start The Week [View article]
"QCOR management indicated that at least 85% of reimbursement requests are ultimately granted. Insurance companies generally want to give patients the drugs their doctors order, as long as a clear need is demonstrated. " I have also read that Medicaid covered it. So as people can select insurance companies based on their needs without being excluded for pre-existing conditions pharma companies will benefit and Aetna may lose these policy holders. Insurance companies no longer run people's healthcare decisions thanks to the Healthcare Affordability Act.
Why IBM's 3Q Results Were Terrible [View article]
Buy IBM To Benefit From Rising Software Profitability [View article]
Buy IBM To Benefit From Rising Software Profitability [View article]
Buy IBM To Benefit From Rising Software Profitability [View article]
Enterprise IT stocks slump following IBM's (IBM -3.7%) Q3 revenue miss, which had much to do with drops in mainframe, storage, and middleware sales. Earnings call remarks about weak September demand aren't helping either, though some might be encouraged IBM's Chinese sales rose 19% Y/Y at a time when others (I, II) are seeing Chinese demand slump. EMC (EMC -1.5%), VMware (VMW -1.9%), Citrix (CTXS -2.2%), Red Hat (RHT -1.7%), and Tibco (TIBX -3.6%) are among the losers. [View news story]
Buy IBM To Benefit From Rising Software Profitability [View article]
IBM has a plan for growth to earnings of $15 this year, with a goal of 50% of earnings coming from high margin software in the next few years. They make their earnings number. This is what matters.
IBM (IBM): Q3 EPS of $3.62 in-line. Revenue of $24.75B (-5% Y/Y) misses by $630M. Expects 2012 EPS of at least $15.10 vs. $15.14 consensus. Shares -3.2% AH. (PR) [View news story]
If you buy stocks when they sell off after earnings, you can make more money than if you buy stocks that have popped. This was in an article by Mark Hulbert on Marketwatch earlier in the year.
I am not selling my IBM stock.
Bill Gross: 'The Ring Of Fire' And Your Income Portfolio [View article]
Earnings Season Launches Under Cloud Of Low Expectations [View article]
Today QCOR is up over 4%. It sold off because of Aetna's decision. I guess Wall Street analysts think that insurance companies will continue to determine people's healthcare decisions and that Romney will repeal the Healthcare Affordability Act. I disagree and do not think that people will go along with that. Even if Romney is elected, I think people will demand the right to switch insurers if they do not cover their doctor's prescription.
To Fight The Fear, Eventually You Have To Shake Your Shorts [View article]
5 Biotech Companies With Major Market-Moving Announcements To Start The Week [View article]
Heavily-shorted Questcor (QCOR +6.1%) surges after receiving more positive sell-side commentary (previous), this time from Jefferies, which is upgrading shares to Buy. Analyst Biren Amin believes investors are pricing Questcor as if almost no insurers will provide coverage for its Acthar gel for treating nephrotic syndrome or MS, something he considers unrealistic. [View news story]
To Fight The Fear, Eventually You Have To Shake Your Shorts [View article]
5 Biotech Companies With Major Market-Moving Announcements To Start The Week [View article]
I have also read that Medicaid covered it.
So as people can select insurance companies based on their needs without being excluded for pre-existing conditions pharma companies will benefit and Aetna may lose these policy holders. Insurance companies no longer run people's healthcare decisions thanks to the Healthcare Affordability Act.
5 Biotech Companies With Major Market-Moving Announcements To Start The Week [View article]